An atlas of genetic influences on human blood metabolites

Shin et al., Nature Genetics, 2014 [ Article | SI Text ]

Locus 13: FMO3 (1q24.3)

Meta-analysis summary statistics for associations meeting genome-wide significance
Lead SNPBiochemicalsEA/OANtotalEAFEffect (SE)PmetaDetails
rs7061710 X-11786--methylcysteine C/G 2773 0.23 0.045 (0.006) 7.52·10-14 show

EA = effect allele; OA = other allele; EAF = frequency of effect allele;

Summary of biological annotations
SNPrs7061710
Chromosomal locationChr1: 169,347,239 (1q24.3)
Gene (distance)FMO3 (0)
Predicted causal geneFMO3
Gene/protein classificationmetabolic enzyme
Metabolite (Pathway)X-11786--methylcysteine (Cysteine, methionine, SAM, taurine metabolism; Amino acid)
Biochemical locus-metabolite relationshipFMO3 can act on S-allyl-cysteine [18775983]. X-11786 was idenfied as methylcysteine and is a possible substrate of FMO3.
eQTL associationsFMO3 (F), FMO3 (S), FMO2 (F), FMO2 (S) †

† F = adipose tissue; S = skin cells; L = lymphoblastoid cells; H = liver cells;

Medical information
Complex trait associations-
Known metabolite associations-
Inborn error of metabolism-

Pharmacological information
ChEMBL ID-
Drug information Substrate: chlorpromazine, trimethylamine, cimetidine

Locus information for top associated metabolite

HapMap2 imputation

Imputation HapMap

1KGP imputation

Imputation 1KGP

 

Network view
Association map